The Rho pathway mediates transition to an alveolar type I cell phenotype during static stretch of alveolar type II cells

Pediatr Res. 2010 Jun;67(6):585-90. doi: 10.1203/PDR.0b013e3181dbc708.

Abstract

Stretch is an essential mechanism for lung growth and development. Animal models in which fetal lungs have been chronically over or underdistended demonstrate a disrupted mix of type II and type I cells, with static overdistention typically promoting a type I cell phenotype. The Rho GTPase family, key regulators of cytoskeletal signaling, are known to mediate cellular differentiation in response to stretch in other organs. Using a well-described model of alveolar epithelial cell differentiation and a validated stretch device, we investigated the effects of supraphysiologic stretch on human fetal lung alveolar epithelial cell phenotype. Static stretch applied to epithelial cells suppressed type II cell markers (SP-B and Pepsinogen C, PGC), and induced type I cell markers (Caveolin-1, Claudin 7 and Plasminogen Activator Inhibitor-1, PAI-1) as predicted. Static stretch was also associated with Rho A activation. Furthermore, the Rho kinase inhibitor Y27632 decreased Rho A activation and blunted the stretch-induced changes in alveolar epithelial cell marker expression. Together these data provide further evidence that mechanical stimulation of the cytoskeleton and Rho activation are key upstream events in mechanotransduction-associated alveolar epithelial cell differentiation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Alveolar Epithelial Cells / drug effects
  • Alveolar Epithelial Cells / enzymology*
  • Amides / pharmacology
  • Biomarkers / metabolism
  • Caveolin 1 / metabolism
  • Cell Differentiation* / drug effects
  • Cell Shape* / drug effects
  • Cells, Cultured
  • Claudins
  • Gestational Age
  • Humans
  • Lung / embryology
  • Lung / enzymology
  • Mechanotransduction, Cellular* / drug effects
  • Membrane Proteins / metabolism
  • Pepsinogen C / metabolism
  • Phenotype
  • Plasminogen Activator Inhibitor 1 / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • Pulmonary Surfactant-Associated Protein B / metabolism
  • Pyridines / pharmacology
  • Stress Fibers / metabolism
  • Time Factors
  • rho-Associated Kinases / antagonists & inhibitors
  • rho-Associated Kinases / metabolism
  • rhoA GTP-Binding Protein / metabolism*

Substances

  • Amides
  • Biomarkers
  • CAV1 protein, human
  • CLDN7 protein, human
  • Caveolin 1
  • Claudins
  • Membrane Proteins
  • Plasminogen Activator Inhibitor 1
  • Protein Kinase Inhibitors
  • Pulmonary Surfactant-Associated Protein B
  • Pyridines
  • SERPINE1 protein, human
  • RHOA protein, human
  • Y 27632
  • Pepsinogen C
  • rho-Associated Kinases
  • rhoA GTP-Binding Protein